HCWB HCW Biologics Inc.: institutional ownership and insider trading
12 funds reported holding $516K of HCW Biologics Inc. in their latest 13F filings; in Q2 2026 funds net bought $516K, with 12 new positions and 0 funds selling out; over the last 12 months insiders bought $532K and sold $0 on the open market.
Famous investors holding HCWB
- Ken Griffin (Citadel Advisors): $99.5K, 0.0% of the portfolio
Largest institutional holders of HCWB
- JANE STREET GROUP, LLC — $260K
- CITADEL ADVISORS LLC — $99.5K
- HRT FINANCIAL LP — $67.0K
- VANGUARD FIDUCIARY TRUST CO — $32.5K
- Tower Research Capital LLC (TRC) — $20.5K
- Connective Capital Management, LLC — $16.7K
- VANGUARD CAPITAL MANAGEMENT LLC — $10.00K
- Golden State Wealth Management, LLC — $8.32K
- BARCLAYS PLC (BCS, BCLYF) — $953
- OSAIC HOLDINGS, INC. — $20
Recent HCWB insider trades
- Jul 29, 2026: Garrett Scott T bought 7,736 shares ($20.0K)
- Jul 29, 2026: Flowers Lee bought 7,736 shares ($20.0K)
- Jul 29, 2026: Wong Hing C bought 23,210 shares ($60.1K)
- May 22, 2026: Byam Rebecca bought 14,235 shares ($20.1K)
5%+ owners
- Hing C. Wong, Ph.D.: 23.4% (Schedule 13D/A, filed Jun 13, 2025)